Activity of apalcillin against Pseudomonas aeruginosa
Gary E. Hollick, Jake Gundrum, Richard A. Venezia
Abstract
Gary E. Hollick, Jake Gundrum, Richard A. Venezia
Abstract
The in vitro activity of apalcillin was tested against 107 clinical isolates of Pseudomonas aeruginosa, and the results were compared to those for piperacillin, mezlocillin, azlocillin, and carbenicillin. MIC analysis showed that 97% of the isolates were susceptible to piperacillin, 97% were susceptible to apalcillin, 93% were susceptible to azlocillin, 87% were susceptible to mezlocillin, and 84% were susceptible to carbenicillin.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The in vitro activity of apalcillin was tested against 107 clinical isolates of Pseudomonas aeruginosa, and the results were compared to those for piperacillin, mezlocillin, azlocillin, and carbenicillin. MIC analysis showed that 97% of the isolates were susceptible to piperacillin, 97% were susceptible to apalcillin, 93% were susceptible to azlocillin, 87% were susceptible to mezlocillin, and 84% were susceptible to carbenicillin.
Key concepts: Azlocillin, Carbenicillin, Mezlocillin, Piperacillin, Pseudomonas aeruginosa, Microbiology, Sisomicin, Biology